ZSAN Explodes, TTPH On Radar, APLS Catches Eyes, CERC Hits A High

Zosano Pharma Corp. gained 71.05% on Monday. The Company's lead drug candidate is M207 for the treatment of migraine. A long-term safety study of M207 is underway.

from RTT - Biotech http://ift.tt/2BUwIO5
via IFTTT